Research News and Research

RSS

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.

21 May 2010

Rush University College of Nursing professor receives Flame of Excellence Award from AACN

The American Association of Critical-Care Nurses will give the Flame of Excellence Award to Ruth Kleinpell at the 2010 National Teaching Institute & Critical Care Exposition, Washington, D.C., May 15-20.

21 May 2010

Pluristem to highlight potential of PLX-PAD cell therapy for critical limb ischemia at 16th ISCT

Pluristem Therapeutics Inc. today announced that its off-the-shelf placenta-derived cell therapies will be the focus of presentations at upcoming investor and medical conferences.

21 May 2010

Study investigates firearm fatalities among under age youths

Over three-quarters of youths under age 15 who die in firearm accidents are shot by another person, usually another youth, according to new research from the Harvard School of Public Health (HSPH).

21 May 2010

Researchers propose steps to enhance patient-physician communication to improve depression care

Because people with depression often do not recognize they have a problem or are unable to describe their distress, many do not seek treatment. About a quarter of those with major depression are undiagnosed, according to several studies, and fewer than half receive treatment.

21 May 2010

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.

21 May 2010

Group weight loss programs reduce risk for type 2 diabetes

The 57 million Americans currently living with "pre-diabetes" could benefit from a group weight loss program, like Weight Watchers, according to a new study published in this month's American Journal of Lifestyle Medicine. Researchers found that after a 6-month Weight Watchers group program, overweight or obese adults who attended at least two thirds of the weekly sessions, not only lost weight, but also significantly reduced fasting glucose and insulin levels - important indicators of diabetes risk.

21 May 2010

Researchers identify drug that improves communication between nerve cells in Phelan-McDermid Syndrome

Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS). Behavioral symptoms of PMS fall under the autism spectrum disorder category. The research will be presented Friday at the International Meeting for Autism Research (IMFAR) in Philadelphia.

21 May 2010

Researchers discover key gene that promotes development of common kidney cancer

Researchers at Mayo Clinic's campus in Florida have discovered a key gene that, when turned off, promotes the development of common kidney cancer. Their findings suggest that a combination of agents now being tested in other cancers may turn the gene back on, providing a much-needed therapy for the difficult-to-treat cancer.

21 May 2010

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).

21 May 2010

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

21 May 2010

New research seeks customised treatment of cardiovascular diseases

The Centre for Cooperative Research in Biomaterials, CIC biomaGUNE, is involved in the research consortium of cvREMOD, which aims to move forward in the attainment of new diagnosis techniques for prevention and customised treatment of cardiovascular diseases in the upcoming four years.

21 May 2010

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

Imagine a chemistry professor and a neuroscientist working together to test a new drug to fight Alzheimer's disease, or a biomedical engineer working with an orthopedic surgeon to help patients walk again.

21 May 2010

New synthesized genome may lead to advances in health and biotechnology

The successful construction of a synthesized genome could enable new research and development of human therapies, biofuels, and biobased chemicals from renewable resources.

21 May 2010

'Teachable moments' can reduce cancer risk in children of parents with mutations in tumor suppressor genes

Parents found to be carriers of a mutated form of the tumor suppressor genes known as BRCA1 and BRCA2 do not always share these test results with their children, but they may choose to discuss related information important to their own health with them. That is the result of a study conducted by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues, whose findings suggest that those parents are using the discovery of their mutation status as an opportunity for a "teachable moment" in educating their offspring about cancer risk reduction.

21 May 2010

Top scientists to share latest research on autism at IMFAR 2010

Autism Speaks, the world's largest autism science and advocacy organization, is a major sponsor and scientific participant in the 2010 International Meeting for Autism Research (IMFAR).

21 May 2010

Restoration of post-meal blood vessel expansion may help improve strength and health in elderly people

Why do people become physically weaker as they age? And is there any way to slow, stop, or even reverse this process, breaking the link between increasing age and frailty?

21 May 2010

Rice University researcher receives 2010 Glycerine Innovation Award

Escherichia coli - E. coli for short - is often identified as a bacterium that contributes to foodborne illness. But research led by a Rice University scientist has discovered ways to use a safe, non-pathogenic E. coli to convert glycerine into high value fuels and chemicals.

21 May 2010

Research team investigates infants with suspected GERD using combined pH/MII monitoring

Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.

21 May 2010

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.

21 May 2010

Research News and Research

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Rush University College of Nursing professor receives Flame of Excellence Award from AACN

Pluristem to highlight potential of PLX-PAD cell therapy for critical limb ischemia at 16th ISCT

Study investigates firearm fatalities among under age youths

Researchers propose steps to enhance patient-physician communication to improve depression care

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Group weight loss programs reduce risk for type 2 diabetes

Researchers identify drug that improves communication between nerve cells in Phelan-McDermid Syndrome

Researchers discover key gene that promotes development of common kidney cancer

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

New research seeks customised treatment of cardiovascular diseases

UF awarded $1.2M grant to support UF-HHMI Science for Life Program

New synthesized genome may lead to advances in health and biotechnology

'Teachable moments' can reduce cancer risk in children of parents with mutations in tumor suppressor genes

Top scientists to share latest research on autism at IMFAR 2010

Restoration of post-meal blood vessel expansion may help improve strength and health in elderly people

Rice University researcher receives 2010 Glycerine Innovation Award

Research team investigates infants with suspected GERD using combined pH/MII monitoring

eGFR as valuable as Ccr as an indicator of preoperative renal function in gastric cancer patients: Study

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News